Page last updated: 2024-09-03

lestaurtinib and Glioma

lestaurtinib has been researched along with Glioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, Y; Kong, S; Meng, Y; Qi, Y; Shang, S; Xin, Y	1

Other Studies

1 other study(ies) available for lestaurtinib and Glioma

Article	Year
Lestaurtinib potentiates TRAIL-induced apoptosis in glioma via CHOP-dependent DR5 induction. Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:14 Topics: Animals; Antineoplastic Agents; Apoptosis; Carbazoles; Caspases; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice; Mice, Knockout; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP; Xenograft Model Antitumor Assays	2020

Article

Year

Lestaurtinib potentiates TRAIL-induced apoptosis in glioma via CHOP-dependent DR5 induction.

Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:14

Topics: Animals; Antineoplastic Agents; Apoptosis; Carbazoles; Caspases; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice; Mice, Knockout; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP; Xenograft Model Antitumor Assays

2020